Assessing the Preparedness and Knowledge of Pharmacists in the Current Monkeypox Outbreak

NCT ID: NCT05543577

Last Updated: 2023-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-14

Study Completion Date

2022-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

General objective: to measure the preparedness of pharmacists and medical interns about monkeypox

Specific objectives: to evaluate the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Globally, the ongoing outbreak was declared as a public health emergency. After the first laboratory-confirmed case of monkeypox was reported in Singapore on May 2019, countries all over the world started to strengthen disease surveillance systems. One challenge in preventing monkeypox is a lack of knowledge, particularly among healthcare workers.

Study significance: to examine in detail the preparedness and the perception of pharmacists and medical interns about monkeypox and to evaluate the level of knowledge about monkeypox management and nature of disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Monkey Pox

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pharmacists

community, hospital and clinical pharmacists

Questionnaire

Intervention Type OTHER

Questionnaire

Medical interns

Medical interns of both sexes

Questionnaire

Intervention Type OTHER

Questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

Questionnaire

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- community, hospital and clinical pharmacists, Medical interns of both sexes

Exclusion Criteria

* any other healthcare professional
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beni-Suef University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Asmaa Abdelfattah Elsayed

Assistant lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Engy Wahsh, Ph.D.

Role: STUDY_DIRECTOR

6october University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

BeniSuefU

Minya, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BeniSuefU2022

Identifier Type: -

Identifier Source: org_study_id